Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction

Dai-Trang (Elizabeth) Le, Eric R. Powers, Jian Ping Bin, Howard Leong-Poi, N. Craig Goodman, Sanjiv Kaul

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Background: The mechanism by which transmyocardial revascularization (TMR) offers clinical benefit is controversial. We hypothesized that TMR ameliorates ischemia by reversing paradoxical catecholamine-induced vasoconstriction. Methods and Results: Chronic ischemic cardiomyopathy was created in 11 dogs by placing ameroid constrictors on the proximal coronary arteries and their major branches. Six weeks later, 35 channels were created percutaneously in the left circumflex artery region, with the left anterior descending artery region serving as control. At rest, wall thickening and myocardial blood flow did not change in the treated region, whereas they deteriorated in the control bed. Contractile and myocardial blood flow reserve increased in the treated region but deteriorated in the control region. There was diminished iodine 123 metaiodobenzylguanidine uptake and a significant reduction in noradrenergic nerves in the treated region compared with the control region, with a corresponding reduction in tissue tyrosine hydroxylase activity. Conclusions: We conclude that the absence of a catecholamine-induced reduction in MBF reserve and contractile reserve in the TMR-treated region with associated evidence of neuronal injury indicates that the relief of exercise-induced ischemia after TMR most likely results from reversal of paradoxical catecholamine-induced vasoconstriction. These findings may have implications in selecting patients who would benefit from TMR.

    Original languageEnglish (US)
    Pages (from-to)207-214
    Number of pages8
    JournalJournal of Nuclear Cardiology
    Volume14
    Issue number2
    DOIs
    StatePublished - Apr 2007

    Fingerprint

    Vasoconstriction
    Catecholamines
    Ischemia
    Arteries
    Tyrosine 3-Monooxygenase
    Cardiomyopathies
    Iodine
    Coronary Vessels
    Dogs
    Exercise
    Wounds and Injuries

    Keywords

    • Cardiomyopathy
    • ischemia
    • lasers
    • revascularization

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction. / Le, Dai-Trang (Elizabeth); Powers, Eric R.; Bin, Jian Ping; Leong-Poi, Howard; Goodman, N. Craig; Kaul, Sanjiv.

    In: Journal of Nuclear Cardiology, Vol. 14, No. 2, 04.2007, p. 207-214.

    Research output: Contribution to journalArticle

    @article{835c250aeb7147e68ce6e2e850c14e28,
    title = "Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction",
    abstract = "Background: The mechanism by which transmyocardial revascularization (TMR) offers clinical benefit is controversial. We hypothesized that TMR ameliorates ischemia by reversing paradoxical catecholamine-induced vasoconstriction. Methods and Results: Chronic ischemic cardiomyopathy was created in 11 dogs by placing ameroid constrictors on the proximal coronary arteries and their major branches. Six weeks later, 35 channels were created percutaneously in the left circumflex artery region, with the left anterior descending artery region serving as control. At rest, wall thickening and myocardial blood flow did not change in the treated region, whereas they deteriorated in the control bed. Contractile and myocardial blood flow reserve increased in the treated region but deteriorated in the control region. There was diminished iodine 123 metaiodobenzylguanidine uptake and a significant reduction in noradrenergic nerves in the treated region compared with the control region, with a corresponding reduction in tissue tyrosine hydroxylase activity. Conclusions: We conclude that the absence of a catecholamine-induced reduction in MBF reserve and contractile reserve in the TMR-treated region with associated evidence of neuronal injury indicates that the relief of exercise-induced ischemia after TMR most likely results from reversal of paradoxical catecholamine-induced vasoconstriction. These findings may have implications in selecting patients who would benefit from TMR.",
    keywords = "Cardiomyopathy, ischemia, lasers, revascularization",
    author = "Le, {Dai-Trang (Elizabeth)} and Powers, {Eric R.} and Bin, {Jian Ping} and Howard Leong-Poi and Goodman, {N. Craig} and Sanjiv Kaul",
    year = "2007",
    month = "4",
    doi = "10.1016/j.nuclcard.2006.12.328",
    language = "English (US)",
    volume = "14",
    pages = "207--214",
    journal = "Journal of Nuclear Cardiology",
    issn = "1071-3581",
    publisher = "Springer New York",
    number = "2",

    }

    TY - JOUR

    T1 - Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction

    AU - Le, Dai-Trang (Elizabeth)

    AU - Powers, Eric R.

    AU - Bin, Jian Ping

    AU - Leong-Poi, Howard

    AU - Goodman, N. Craig

    AU - Kaul, Sanjiv

    PY - 2007/4

    Y1 - 2007/4

    N2 - Background: The mechanism by which transmyocardial revascularization (TMR) offers clinical benefit is controversial. We hypothesized that TMR ameliorates ischemia by reversing paradoxical catecholamine-induced vasoconstriction. Methods and Results: Chronic ischemic cardiomyopathy was created in 11 dogs by placing ameroid constrictors on the proximal coronary arteries and their major branches. Six weeks later, 35 channels were created percutaneously in the left circumflex artery region, with the left anterior descending artery region serving as control. At rest, wall thickening and myocardial blood flow did not change in the treated region, whereas they deteriorated in the control bed. Contractile and myocardial blood flow reserve increased in the treated region but deteriorated in the control region. There was diminished iodine 123 metaiodobenzylguanidine uptake and a significant reduction in noradrenergic nerves in the treated region compared with the control region, with a corresponding reduction in tissue tyrosine hydroxylase activity. Conclusions: We conclude that the absence of a catecholamine-induced reduction in MBF reserve and contractile reserve in the TMR-treated region with associated evidence of neuronal injury indicates that the relief of exercise-induced ischemia after TMR most likely results from reversal of paradoxical catecholamine-induced vasoconstriction. These findings may have implications in selecting patients who would benefit from TMR.

    AB - Background: The mechanism by which transmyocardial revascularization (TMR) offers clinical benefit is controversial. We hypothesized that TMR ameliorates ischemia by reversing paradoxical catecholamine-induced vasoconstriction. Methods and Results: Chronic ischemic cardiomyopathy was created in 11 dogs by placing ameroid constrictors on the proximal coronary arteries and their major branches. Six weeks later, 35 channels were created percutaneously in the left circumflex artery region, with the left anterior descending artery region serving as control. At rest, wall thickening and myocardial blood flow did not change in the treated region, whereas they deteriorated in the control bed. Contractile and myocardial blood flow reserve increased in the treated region but deteriorated in the control region. There was diminished iodine 123 metaiodobenzylguanidine uptake and a significant reduction in noradrenergic nerves in the treated region compared with the control region, with a corresponding reduction in tissue tyrosine hydroxylase activity. Conclusions: We conclude that the absence of a catecholamine-induced reduction in MBF reserve and contractile reserve in the TMR-treated region with associated evidence of neuronal injury indicates that the relief of exercise-induced ischemia after TMR most likely results from reversal of paradoxical catecholamine-induced vasoconstriction. These findings may have implications in selecting patients who would benefit from TMR.

    KW - Cardiomyopathy

    KW - ischemia

    KW - lasers

    KW - revascularization

    UR - http://www.scopus.com/inward/record.url?scp=33947408375&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33947408375&partnerID=8YFLogxK

    U2 - 10.1016/j.nuclcard.2006.12.328

    DO - 10.1016/j.nuclcard.2006.12.328

    M3 - Article

    VL - 14

    SP - 207

    EP - 214

    JO - Journal of Nuclear Cardiology

    JF - Journal of Nuclear Cardiology

    SN - 1071-3581

    IS - 2

    ER -